Nektar Therapeutics Statistics
NASDAQ: NKTRHealth CareBiotechnology: Pharmaceutical PreparationsUSD
30.20-2.34 (-7.19%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Nektar Therapeutics by the numbers
Nektar Therapeutics has a market capitalization of $1.03 billion based on 34.21M shares outstanding. With trailing EPS of $-22.47, Nektar Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 32.3% below its 50-day average and 53.5% below its 200-day average.
Average daily trading volume is 1.12M shares, or about $33.8 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
NKTR valuation vs. peer median
| Metric | NKTR | Peer median | Difference |
|---|---|---|---|
| Market cap | $1.03B | $1.02B | +1% |
| Avg. volume | 1.12M | 620.37K | +81% |
Peer median across 8 companies: CTY, ANRO, JBIO, KARD, OMER, SPTX, CYRX, AAPG.
Valuation
- Market cap
- $1.03B
- Price / sales (latest FY)
- 18.71
- EPS (TTM)
- $-22.47
- Shares outstanding
- 34.21M
Price and trading
- Previous close
- 32.54
- Open
- 31.66
- Day range
- 30.13 – 32.35
- 52-week range
- 30.13 – 109.00
- 52-week change
- -44.36%
- Beta
- —
- Volume
- 1.02M
- Average volume
- 1.12M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 12, 2026
Additional statistics
- Market Cap
- 1.03B
- Forward Pe
- -3.04
- Eps
- -22.47
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 109.00
- Week52 Low
- 30.13
- Avg Volume
- 1.12M
- Shares Outstanding
- 34.21M
- Ma50
- 44.60
- Ma200
- 64.96
- Earnings Date
- Nov 12, 2026
- Pct From52w High
- -72.29%
- Pct From52w Low
- 0.23%